DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”), announced today the voting results on the election of directors from its 2022 annual general and special meeting of shareholders of the Company (the “Meeting”).

A total of 38,697,020 common shares of the Company (“Shares”) representing 33.39% of the 115,891,097 issued and outstanding Shares were voted in connection with the Meeting. Shareholders approved all items of business before the Meeting, including the election of directors as follows:

Shareholders also voted in favour of fixing the number of directors at five, the reappointment of Baker Tilly HMA LLP as the auditors of the Company until the close of the next annual meeting of shareholders of the Company and the ratification of the previously completed private placement of a $10,000,000 principal amount 3 year 10% senior second-lien secured convertible debenture of the Company (the “Sundial Debenture”) to Sundial Growers Inc. for a subscription price of $9,600,000 and certain amendments to the Sundial Debenture.

For more information contact:

Investor & Media Contact:
Ian Chadsey, VP Corporate Affairs
Mobile: 204-898-7722
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. 

About Delta 9 Cannabis Inc.

Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9's shares trade on the Toronto Stock Exchange under the symbol "DN" and on the OTCQX under the symbol "DLTNF". For more information, please visit www.delta9.ca.